Lisa Juntti-Berggren

6PUBLICATIONS
12CO-AUTHORS
Cancer geneticsExercise physiologyMolecular targetsAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
siRNA-Mediated Reduction of Apolipoprotein CIII Delays Pancreatic Islet Deterioration and Onset of Type 1 Diabetes in Diabetes-Prone BioBreeding Rats.

|Feb 13, 2025
Differential Regulation of miRNA and Protein Profiles in Human Plasma-Derived Extracellular Vesicles via Continuous Aerobic and High-Intensity Interval Training.

Zhenghao Wang, Yiran Ou, Xinyue Zhu

|Aug 30, 2022
Treatment of the metabolic syndrome by siRNA targeting apolipoprotein CIII.

Patricia Recio-López, Ismael Valladolid-Acebes, Philipp Hadwiger

|Jan 11, 2022
Apolipoprotein CIII Reduction Protects White Adipose Tissues against Obesity-Induced Inflammation and Insulin Resistance in Mice.

Patricia Recio-López, Ismael Valladolid-Acebes, Per-Olof Berggren

|Mar 13, 2021
Lowering apolipoprotein CIII protects against high-fat diet-induced metabolic derangements.

Ismael Valladolid-Acebes, Karin Åvall, Patricia Recio-López

Pageof 1

Frequent Collaborators

2 joint publications

Ismael Valladolid-Acebes

1 joint publications

Karin Åvall

1 joint publications

Noah Moruzzi

1 joint publications

Anna Krook